Home › NDC Lookup › RxCUI directory › RxCUI 855635

Diclofenac sodium 0.01 MG/MG Topical Gel [Voltaren] — RxCUI 855635

RxNorm drug concept · Semantic branded drug
RxCUI 855635 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI855635
Official nameDiclofenac sodium 0.01 MG/MG Topical Gel [Voltaren]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVoltaren 1 % Topical Gel; Voltaren 0.01 MG/MG Topical Gel
FDA products mapped4
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They calm inflammation after cataract surgery. They also temporarily ease pain and light sensitivity after corneal refractive surgery, such as PRK or radial keratotomy.
  • After cataract surgery, it is usually about 4 times a day, starting the day after surgery for the first 2 weeks. For refractive surgery, you use drops before and right after the pr...
  • Brief burning or stinging is the most common complaint, affecting about 15% of people. It usually passes quickly. Tell your doctor if it persists or you notice blurred vision, redn...
  • Be careful and tell your doctor first. People sensitive to aspirin or other NSAIDs may also react to diclofenac. You should not use the drops if you are allergic to any ingredient...
📖 Read our full Diclofenac Ophthalmic guide →

🕸️ Concept Web — How Diclofenac sodium 0.01 MG/MG Topical Gel [Voltar... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Diclofenac sodium 0.01 MG/MG Topical Gel [Voltaren] RxCUI 855635

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Diclofenac 3355
    • Diclofenac sodium 203214
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Voltaren 202976
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diclofenac Topical Gel 377959
    • Diclofenac sodium Topical Gel 2648310
    • Diclofenac Topical Product 1151155
    • Diclofenac sodium Topical Product 2659220
    • Diclofenac Topical Gel [Voltaren] 752882
    • Diclofenac sodium Topical Gel [Voltaren] 2656719
    • Voltaren Topical Product 1187421
    • Topical Gel 346286
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diclofenac sodium 0.01 MG/MG Topical Gel SCD · 855633
  • Diclofenac sodium 0.01 MG/MG SCDC · 855632
  • Diclofenac Topical Gel SCDF · 377959
  • Diclofenac sodium Topical Gel SCDFP · 2648310
  • Diclofenac Topical Product SCDG · 1151155
  • Diclofenac sodium Topical Product SCDGP · 2659220

Brand-Name Concepts

  • Diclofenac sodium 0.01 MG/MG [Voltaren] SBDC · 855634
  • Diclofenac Topical Gel [Voltaren] SBDF · 752882
  • Diclofenac sodium Topical Gel [Voltaren] SBDFP · 2656719
  • Voltaren Topical Product SBDG · 1187421
  • Voltaren BN · 202976

📦 FDA Products & Package NDCs

4 products · 9 package NDCs
9 package NDCs map to RxCUI 855635 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00067-8152-01 1 TUBE in 1 CARTON (0067-8152-01) / 20 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2020-05-13
00067-8152-02 1 TUBE in 1 CARTON (0067-8152-02) / 50 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2020-05-13
00067-8152-03 1 TUBE in 1 CARTON (0067-8152-03) / 100 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2020-05-13
00067-8152-04 1 TUBE in 1 CARTON (0067-8152-04) / 150 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2020-05-13
00067-8152-08 2 TUBE in 1 CARTON (0067-8152-08) / 100 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2021-05-31
00067-8152-09 1 TUBE in 1 CARTON (0067-8152-09) / 20 g in 1 TUBE Voltaren Arthritis Pain Haleon US Holdings LLC 2021-05-31
00067-8153-01 1 KIT in 1 CARTON (0067-8153-01) * 2 TUBE in 1 KIT / 150 g... Voltaren Arthritis Pain Haleon US Holdings LLC 2020-05-13
00067-8154-01 1 KIT in 1 CARTON (0067-8154-01) * 1 TUBE in 1 CARTON (006... Voltaren Arthritis Pain Haleon US Holdings LLC 2025-02-19
50090-6202-00 24 TUBE in 1 CASE (50090-6202-0) / 50 g in 1 TUBE VOLTAREN ARTHRITIS PAIN A-S Medication Solutions 2022-11-02
Observed labelers: Haleon US Holdings LLC (8) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.